Skip to main content

2025 IDWeek Main banner

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Session Icons

Live Streamed

On Demand

60 Views

Z13. COVID-19 Other

Poster Session: COVID-2019 and Co-Infections

(P-1631) Physician Perceptions and Decision-Making Factors in Prescribing COVID-19 Antivirals: Qualitative Research Findings

Wednesday, October 22, 2025

12:15 PM - 1:30 PM US ET

Location: Poster Hall B4-B5

Presenting Author(s)

MF

Maria Fernandez, PhD, MBA

Director Global Access & Value--Anti-infectives
Pfizer
Chapel Hill, NC, United States

Co-Author(s)

DF

Domenick Francis, PharmD

Director, US Medical Affairs
Pfizer
New York, New York, United States
IA

Iqra Naz Arham, PharmD, RPH

Medical Director
Pfizer
New York, New York, United States
JC

Joshua R. Coulter, MA

Director, Preference Elicitation
Pfizer
New York, New York, United States
BH

Brett Hauber, PhD

Pfizer, Inc.
New York, New York, United States
SK

Shoaib Khan, MD

Medical Director
Pfizer
New York, New York, United States
LK

Lewis Kopenhafer, BA

Oracle America, Inc.
Los Angeles, Virginia, United States
WY

William You, MSPH

Associate Research Director
Oracle Life Sciences
Austin, Texas, United States
KB

Kathleen Beusterien, MPH

Oracle Life Sciences
Austin, Texas, United States
MM

Martine C. Maculaitis, PhD, MA

Oracle Life Sciences
Austin, Texas, United States
SH

Soohyun Hwang, PhD, MPH

Senior Research Consultant
Oracle Life Sciences
Santa Clara, California, United States
MD

Michael J. DiGiovanna, DO

Chief Medical Officer
DiGiovanna Family Care Center A Division of NY Health
Smithtown, New York, United States
MM

Mary M. Moran, MD

Pfizer Inc.
Collegeville, Pennsylvania, United States
RM

Ruth Mokgokong, PhD

Pfizer
Tadworth, England, United Kingdom